← Leaderboards
Gary J. Gibson
Henry Ford Health System
$2,919,388
Attributed
$2,919,388
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $496.3K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,919,388 · 3
By mechanism
R01$1,787,285 · 1
RC1$988,103 · 1
R21$144,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Henry Ford Health System
Same institution · by research overlap
- Nour-Eddine Rhaleb$4,498,249
- David P Fyhrie$1,574,143
- Jae Ho Kim$5,625,109
- Clifford Michael Les$2,201,814
- Oscar A. Carretero$13,917,720
Others in their field
Top investigators on “Chondrocytes”
- Martin K. Lotz · Scripps Research Institute$20,021,168
- Farshid Guilak · Duke University$19,379,279
- Veronique M Lefebvre · University Of Texas Md Anderson Can Ctr$17,871,341
- Qian Chen · Rhode Island Hospital$17,579,507
- Richard F Loeser · Rush University Medical Center$16,293,126
- Maurizio Pacifici · University Of Pennsylvania$13,073,083
Research focus
ChondrocytesInterleukin 1High Performance Liquid ChromatographyAngiogenesis FactorOsteoarthritisTissue /Cell CultureEnzyme Linked Immunosorbent AssayWestern BlottingsSds Polyacrylamide Gel ElectrophoresisChick EmbryoChemotaxisNormal OssificationAce InhibitorsElectron MicroscopyApoptosisMass SpectrometryTransforming Growth FactorsProtein PurificationAffinity ChromatographyArticular CartilageMolecular CloningMolecular ShapeCartilageCarbohydrates
Grant awards (10)
Serum microRNAs as biomarkers of post-traumatic osteoarthritis$491,770
RC1 · FY2010 · AR · contact PI
Serum microRNAs as biomarkers of post-traumatic osteoarthritis$496,333
RC1 · FY2009 · AR · contact PI
Chondrocyte Apoptosis and Release of Angiogenic Factors$302,319
R01 · FY2006 · AR · contact PI
Chondrocyte Apoptosis and Release of Angiogenic Factors$309,595
R01 · FY2005 · AR
THE ROLE OF GLYCATION END PRODUCTS IN CARTILAGE DAMAGE$72,000
R21 · FY2005 · AR
Chondrocyte Apoptosis and Release of Angiogenic Factors$336,050
R01 · FY2004 · AR
THE ROLE OF GLYCATION END PRODUCTS IN CARTILAGE DAMAGE$72,000
R21 · FY2004 · AR
Chondrocyte Apoptosis and Release of Angiogenic Factors$336,050
R01 · FY2003 · AR
Chondrocyte Apoptosis and Release of Angiogenic Factors$316,214
R01 · FY2002 · AR
CHONDROCYTE APOPTOSIS AND RELEASE OF ANGIOGENIC FACTORS$187,057
R01 · FY2000 · AR